Crossject Quote - ALCJ

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

Bid

Offer

Volume

0.00 Day's Range 0.00

0.7502 52 Week Range 2.75

Market Cap

Previous Close

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

184,917

Shares Outstanding

36,763,256

Dividend Yield

PE Ratio

-4.09

Earnings Per Share (EPS)

-0.24

Revenue

9.14M

Net Profit

-8.64M

Sector

Med, Dental, Hosp Eq-whsl

Industry

Med, Dental, Hosp Eq-whsl

Website

www.crossject.com

Headquarters

Dijon, Cote-d'or, Fra

Founded

Crossject is listed in the Med, Dental, Hosp Eq-whsl sector of the Euronext with ticker ALCJ. The last closing price for Crossject was -. Over the last year, Crossject shares have traded in a share price range of 0.7502 € to 2.75 €.

Crossject currently has 36,763,256 shares in issue. Crossject has a price to earnings ratio (PE ratio) of -4.09.

Patrick ALEXANDRE, Fondateur et PDG, revient sur le point d’étape publié lors de la présentation des comptes annuels 2024

Patrick ALEXANDRE, Fondateur et PDG, revient sur le point d’étape publié lors de la présentation des comptes annuels 2024 Communiqué de presse...

CROSSJECT reports financial results for 2024

CROSSJECT reports financial results for 2024 Press Release CROSSJECT reports financial results for 2024 Continued satisfactory production of...

CROSSJECT publie ses résultats financiers pour 2024

CROSSJECT publie ses résultats financiers pour 2024 Communiqué de presse CROSSJECT publie ses résultats financiers pour 2024 Continuité dans la...

CROSSJECT fait le point sur sa collaboration avec ETON PHARMACEUTICALS, Inc. et sur le programme ZENEO® Hydrocortisone dans le domaine de l'insuffisance surrénale

CROSSJECT fait le point sur sa collaboration avec ETON PHARMACEUTICALS, Inc. et sur le programme ZENEO® Hydrocortisone dans le domaine de...

CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program

CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program Press Release CROSSJECT...

CROSSJECT achieves key ZEPIZURE® manufacturing batch stability milestones

CROSSJECT achieves key ZEPIZURE® manufacturing batch stability milestones Press Release CROSSJECT achieves key ZEPIZURE® manufacturing batch...

CROSSJECT franchit une étape clé dans la stabilité des lots produits de ZEPIZURE®

CROSSJECT franchit une étape clé dans la stabilité des lots produits de ZEPIZURE® Communiqué de presse CROSSJECT franchit une étape clé dans la...

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social Communiqué de Presse Information...

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social Communiqué de Presse Information...

Crossject annonce le renouvellement de Patrick Alexandre et Isabelle Liebschutz dans leurs fonctions de membres d’un nouveau Directoire ressérré

Crossject annonce le renouvellement de Patrick Alexandre et Isabelle Liebschutz dans leurs fonctions de membres d’un nouveau Directoire ressérré...

Period	Open	High	Low	Avg. Daily Vol	VWAP
1	0.93	1.06	0.8633	152986	0.91486677	DE
4	1.45	1.45	0.7502	332823	1.0120424	DE
12	2	2.075	0.7502	184917	1.36080764	DE
26	2.365	2.365	0.7502	134224	1.6015655	DE
52	2.05	2.75	0.7502	102164	1.77386057	DE
156	1.9	5.96	0.7502	92314	3.04499234	DE
260	1.64	5.96	0.7502	130001	3.04093217	DE

ALCJ - Frequently Asked Questions (FAQ)

What is the current Crossject share price?

The current share price of Crossject is 0.00 €

How many Crossject shares are in issue?

Crossject has 36,763,256 shares in issue

What is the 1 year trading range for Crossject share price?

Crossject has traded in the range of 0.7502 € to 2.75 € during the past year

What is the PE ratio of Crossject?

The price to earnings ratio of Crossject is -4.09

What is the cash to sales ratio of Crossject?

The cash to sales ratio of Crossject is 3.86

What is the reporting currency for Crossject?

Crossject reports financial results in EUR

What is the latest annual turnover for Crossject?

The latest annual turnover of Crossject is EUR 9.14M

What is the latest annual profit for Crossject?

The latest annual profit of Crossject is EUR -8.64M

What is the registered address of Crossject?

The registered address for Crossject is 6 RUE PAULINE KERGOMARD - ZAC PARC MAZEN SULLY, DIJON, COTE-D'OR, 21000

What is the Crossject website address?

The website address for Crossject is www.crossject.com

Which industry sector does Crossject operate in?

Crossject operates in the MED, DENTAL, HOSP EQ-WHSL sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PHXMPHAXIAM Therapeutics SA	0.468 € (208.91%)	512.65k
DMSBSDiagnostic Medical Systems	0.009 € (157.14%)	5.55k
ALSENSensorion	0.4065 € (94.31%)	4.53M
MLCOTCoretech 5	0.0295 € (47.50%)	21.4k
CLEXCumulex NV	1.30 € (38.30%)	200
ALALOAcheterLouerFR	0.0003 € (-25.00%)	49.2M
MLGEQGentlemen S Equity SA	0.015 € (-18.92%)	400
FPGUnion Tech Info	0.10 € (-15.97%)	5.58k
ALVERVergnet	0.0006 € (-14.29%)	337.31M
ALNMRNamR SA	0.243 € (-13.83%)	10k
ALVERVergnet	0.0006 € (-14.29%)	337.31M
ALEUPEuroplasma	0.0148 € (-12.94%)	263.34M
BCPBanco Comercial Portugues SA	0.5616 € (-1.20%)	74.89M
ALALOAcheterLouerFR	0.0003 € (-25.00%)	49.2M
ALHPIHopium SA	0.0009 € (0.00%)	43.95M